Literature DB >> 30559584

Ertugliflozin (Steglatro): A New Option for SGLT2 Inhibition.

Nikolas Kovacich, Benjamin Chavez.   

Abstract

Steglatro (ertugliflozin) for glycemic control in adults with type-2 diabetes mellitus.

Entities:  

Year:  2018        PMID： 30559584      PMCID： PMC6281144     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  2 in total

1.  Euglycemia despite a sodium glucose co-transporter 2 inhibitor overdose.

Authors:  Muhammad Akbar Baig; Joshua Nogar
Journal:  World J Emerg Med       Date:  2022

2.  Knowledge and practice of community pharmacists towards SGLT2 inhibitors.

Authors:  Abdelrahim Alqudah; Muna Oqal; Ahmad Al-Samdi; Esam Qnais; Mohammed Wedyan; Majd Abu Gneam; Roaa Alnajjar; Manar Alajarmeh; Elaf Yousef; Omar Gammoh
Journal:  F1000Res       Date:  2022-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.